Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.
Press releases published on October 2, 2025
Young Innovations Introduces American Eagle Instruments® XP² to the U.S. Market
Algonquin, IL, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Young Innovations, Inc. (“Young”), a leading global manufacturer and distributor of dental products, has announced the launch of XP², a proprietary, scientifically driven, next generation line of innovative …
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to prevent AMD progression and preserve central vision IRAK-M levels decrease with age and more prominently in people …
24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature’s Toughest Fiber
DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in …
Positron Corporation Enters Industry Partnership Agreement with MedAxiom
Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical services is pleased to announce a …
Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting
Initial Phase 1 data suggest PRTH-101 contributes to disease control in recurrent/metastatic thymic epithelial carcinoma (TEC) with median progression-free survival (mPFS) of 7.9 months and 1 partial response (PR) observed Pivotal Phase 2 trial for the …
Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
FORT WORTH, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced that the …
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
THE WOODLANDS, TX, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the next CEO Corner segment has …
AI Model Predicts Increase in Women Likely to Get Screening Mammograms
GREENWICH, Conn., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cedar Gate Technologies (Cedar Gate), a leading value-based care technology and services company, today announced new data revealing that the number of women likely to miss their recommended screening …
Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization
CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer (CCO), effective October …
Sienna Senior Living Completes Acquisition in Greater Toronto Area
MARKHAM, Ontario, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has finalized its acquisition of Cawthra Gardens, a 192-bed Class A long-term care home in Mississauga, Ontario, …
Stride Autism Centers Opens New Bellevue, Nebraska Clinic, Expanding Access to Early Intervention ABA Therapy
BELLEVUE, Neb., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, the Midwest’s leading provider of center-based Applied Behavior Analysis (ABA) therapy for young children with autism, is proud to announce the grand opening of its sixth Nebraska …
CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Company management will participate in a …
Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025
ORANGE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2025 financial results on Thursday, Oct. 30, 2025, after market close. Following the release, the company will host a conference …
Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for …
Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference
CUPERTINO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
BOTHELL, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the Noble Capital Markets Emerging Growth Virtual Equity …
BioCardia Regains Compliance with Nasdaq Listing Requirements
SUNNYVALE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has regained compliance with the Nasdaq …
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
PRINCETON, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive …
Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing
PARAMUS, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, announced today the promotion of Rod …